Remove Health Data Remove Life Science Remove mHealth Remove Mobile Health

What HealthyThinker Is Thinking About Health at CES 2020

Health Populi

At #CES2020, exhibitors in the health/care ecosystem will go well beyond wearable devices for tracking steps and heart rate. I’ve also scheduled get-togethers with pharma and life science folks, health plan people, and execs from consumer health companies.

Dave Ryan, Intel GM for IoT in Healthcare and the Future of Remote Care – Harlow On Healthcare

Health Blawg

My guest for this edition is Dave Ryan, Intel GM for Health and Life Sciences at its Internet of Things Group. IoT is not necessarily just about remote sensors, and in fact the IoT story is two different stories – one inside the health care facility, and one outside.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Dave Ryan, Intel GM for IoT in Healthcare and the Future of Remote Care – Harlow On Healthcare

Health Blawg

My guest for this edition is Dave Ryan, Intel GM for Health and Life Sciences at its Internet of Things Group. IoT is not necessarily just about remote sensors, and in fact the IoT story is two different stories – one inside the health care facility, and one outside.

Dave Ryan, Intel GM for IoT in Healthcare and the Future of Remote Care – Harlow On Healthcare

Health Blawg

My guest for this edition is Dave Ryan, Intel GM for Health and Life Sciences at its Internet of Things Group. IoT is not necessarily just about remote sensors, and in fact the IoT story is two different stories – one inside the health care facility, and one outside.

Dave Ryan, Intel GM for IoT in Healthcare and the Future of Remote Care – Harlow On Healthcare

Health Blawg

My guest for this edition is Dave Ryan, Intel GM for Health and Life Sciences at its Internet of Things Group. IoT is not necessarily just about remote sensors, and in fact the IoT story is two different stories – one inside the health care facility, and one outside.

5 Digital Health Predictions for 2018 by Lloyd Price

Lloyd Price

The acquisition will effectivey be a "trojan horse" unlocking access to data, clinical technology, mobile technology, paying clients and research. The program also supports independent mobile app developers who target providers and patients.

FHIR 97